Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; BC Diabetes, Vancouver, British Columbia, Canada.
Can J Diabetes. 2017 Jun;41(3):297-304. doi: 10.1016/j.jcjd.2016.10.012. Epub 2017 Mar 18.
To examine the effects of a 6-month nurse case manager (NCM) intervention compared to standard care (SC) on glycemic control and diabetes distress in a Canadian tertiary-care setting.
We recruited 140 adults with type 2 diabetes and glycated hemoglobin (A1C) levels >8% (64 mmol/mol) from 2 tertiary care facilities and randomized them to: 1) a 6-month NCM intervention in addition to SC or 2) SC by the primary endocrinologists. Assessments were conducted at baseline and at 6 months. Primary outcomes included A1C levels and diabetes distress scores (DDS). Secondary outcomes included body mass index, blood pressure, diabetes-related behaviour measures, depressive symptoms, self-motivation and perception of support.
At the 6-month follow up, the NCM group experienced larger reductions in A1C levels of -0.73% compared to the SC group (p=0.027; n=134). The NCM group also showed an additional reduction of -0.40 (26% reduction) in DDS compared to those in the SC group (p=0.001; n=134). The NCM group had lower blood pressure, ate more fruit and vegetables, exercised more, checked their feet more frequently, were more motivated, were less depressed and perceived more support. There were no changes and no group differences in terms of body mass index, medication compliance or frequency of testing.
Compared to SC, NCM intervention was more effective in improving glycemic control and reducing diabetes distress. It is, therefore, a viable adjunct to standard diabetes care in the tertiary care setting, particularly for patients at high risk and with poor control.
在加拿大的一家三级保健机构中,研究 6 个月的护士个案经理(NCM)干预与标准护理(SC)相比对血糖控制和糖尿病困扰的影响。
我们从 2 家三级保健机构招募了 140 名糖化血红蛋白(A1C)水平>8%(64mmol/mol)的 2 型糖尿病成人,并将他们随机分为:1)除 SC 外还进行 6 个月的 NCM 干预,或 2)由初级内分泌学家进行 SC。在基线和 6 个月时进行评估。主要结局包括 A1C 水平和糖尿病困扰评分(DDS)。次要结局包括体重指数、血压、糖尿病相关行为措施、抑郁症状、自我激励和感知支持。
在 6 个月的随访中,NCM 组的 A1C 水平下降了-0.73%,而 SC 组下降了-0.28%(p=0.027;n=134)。与 SC 组相比,NCM 组的 DDS 也降低了-0.40(26%的降幅)(p=0.001;n=134)。NCM 组的血压较低,摄入更多的水果和蔬菜,锻炼更多,更频繁地检查脚,更有动力,抑郁症状较轻,感知到更多的支持。在体重指数、药物依从性或测试频率方面,没有变化,也没有组间差异。
与 SC 相比,NCM 干预在改善血糖控制和减轻糖尿病困扰方面更有效。因此,它是三级保健环境中标准糖尿病护理的可行辅助手段,特别是对于高风险和控制不佳的患者。